Home About Us Government Relations and Advocacy Media Contact Us Site Map Privacy  
Multiple Sclerosis Society of Canada Société canadienne de la sclérose en plaques Finding a cure  Enhancing quality of life
About Multiple Sclerosis Living with Multiple Sclerosis Research Treatments Donate Now Get Involved Special Events

Ottawa Chapter


Research Highlights

In this section, from time to time, we will highlight research taking place locally within Ottawa and the surrounding communities. Research highlighted here may help progress towards finding a cure for MS or discover new therapies and approaches that will play a role in the relief of symptoms of MS.

A Model System to Grow Oligodendrocytes

Introduction

In the first local highlight, we present recent research performed by a team at the Ottawa Hospital Research Institute. This research group has developed a model system that allows them to study oligodendrocytes in cultured dishes. Oligodendrocytes are cells in the brain that produce the fatty protective layer (called myelin) around neurons (cells that carry nerve impulses). Slow degeneration of myelin leads to neuromuscular disorders such as Multiple Sclerosis. By studying these cells in cultured dishes, Scientists can more directly observe how these cells behave and interact. They can also understand the triggers needed to make these cells produce myelin and directly test how these cells respond to drugs and other treatments. With the fast-paced advances in MS-drug therapy, this oligodendrocyte model system could be very important in determining which drugs are better suited for clinical trials.

The Team

Text Box:

Dr. Rashmi Kothary of the Ottawa Hospital Research Institute leads a world class program investigating the molecular events in oligodendrocyte myelination and myelin repair. He recently received the Dr. J. David Grimes Research Career Achievement Award in 2011 for his contributions toward understanding how nerve fibers regenerate myelin in Multiple Sclerosis as well as genetic mechanisms in other neurological disorders. Dr. Kothary is a strong mentor for many younger scientists and trainees in the field of MS and is a highly valued member of the local Ottawa research community. For a more detailed biography of Dr. Kothary, CLICK HERE, and for details on his Research Awards, CLICK HERE.

Text Box:

Ryan O'Meara, a Ph.D. student training under Dr. Kothary's mentorship has developed a model system to grow oligodendrocytes in culture dishes. Traditionally this has been very difficult to do. The contribution by Dr. Kothary's team may provide a fast way to screen candidate drugs for treating MS.

Ryan O'Meara's Description of the Work

Oligodendrocytes are the cell type which provides the myelin in the brain – the fatty material that is lost in Multiple Sclerosis. This fatty material is important for the survival and function of neurons, which are the cell type that allows for communication between the brain and the body. It is important for researchers to learn about this cell type, in order to test and develop new drugs that may promote regeneration of myelin in Multiple Sclerosis.

Researchers often extract cells from mice and study them in Petri dishes to help understand their basic biological processes. A major hurdle in oligodendrocyte research is that there is little published information on methods for extracting and growing these cells from mice. Our lab has recently published a method that allows for fast, easy isolation of this cell type for their observation in Petri dishes. In addition, the new protocol describes methods on how to combine neurons and oligodendrocytes together to observe how they interact to produce myelin.

One significant use of this cell technique is for screening new drugs to determine their effect on oligodendrocytes. Delivery of drugs to the oligodendrocytes will lend insight into whether these medications play a positive effect on the production of myelin. As many new MS drugs are of the oral type, this method would be a fast and easy way to test the effect of these therapies directly on this afflicted cell type.

 This research has also been published in a video format.

A very interesting look at the laboratory process described above is shown in a video publication of the method. CLICK HERE to view the video.

Highlights of Other Research

Selected research activities towards finding a cure or developing therapies reported on the MS Society National Web Site are highlighted here in this section. For the most up-to-date research alerts, please go the MS Society News in Research page.

Calnexin Deficiency Leads to Dysmyelination

Why This Research is Important: In these studies, mice were genetically altered so that they could not make the protein calnexin. The researchers showed that without calnexin, nervous impulses were transmitted more slowly and as a result, these nerve cells were losing myelin. Consequently, they concluded that calnexin is a protein that helps to form myelin.

Summary of Research: Researchers have identified a gene that leads to a chain of events which impacts the speed at which messages are relayed in the nervous system. 

CLICK HERE  for more information.

A Home-Based Walking Program Using Rhythmic Auditory Stimulation Improves Gait Performance in Patients With Multiple Sclerosis

Why This Research is Important: Although a larger study is required, this pilot study demonstrates that RAS can have beneficial effects on walking performance in MS patients. This is a simple and low-cost intervention for MS patients that experience movement/walking (gait) difficulties.

Summary of Research: A Pilot Study. Few interventions have been successful in improving gait dysfunction in patients with multiple sclerosis (MS). Rhythmic auditory stimulation (RAS) has demonstrated positive results on gait performance in other neurologically impaired populations. 

CLICK HERE  for more information.

The Effect of Microvascular Decompression in Patients With Multiple Sclerosis and Trigeminal Neuralgia

Why This Research is Important: This research suggests that microvascular decompression can relieve pain and greatly benefit MS patients with trigeminal neuralgia.

Summary of Research: Trigeminal neuralgia (TN) in patients with multiple sclerosis (MS) is thought to be caused by demyelinating plaques within the nerve root entry zone, the trigeminal nucleus, or the trigeminal tracts. Authors review their experience of microvascular decompression (MVD) in patients with MS and symptomatic TN. 

CLICK HERE  for more information.

The natural history of secondary progressive multiple sclerosis

Summary of Research: The onset of secondary progression is a pivotal event in the course of relapsing-remitting (RR) multiple sclerosis (MS). Patients with secondary progressive MS (SPMS) experience continuous worsening of symptoms independent of the occurrence of relapses. Possible risk factors associated with the onset of SPMS remain under investigated in natural history studies of MS disease course.

CLICK HERE  for more information.

Last Updated: March 14, 2012

Top

© Multiple Sclerosis Society of Canada

 

Multiple Sclerosis   Living with MS   Research   Treatments   Donate Now   Get Involved    Special Events

Home    About Us    Advocacy    Media    Contact Us    Site Map    Privacy    Français